Results 261 to 270 of about 392,253 (296)
Some of the next articles are maybe not open access.

Rationale for adjuvant chemotherapy

Cancer, 1977
Surgery or radiation therapy fails to cure clinically evident human cancer, in the main, if the disease is systemic (has metastasized) when first recognized, because neither modality can effectively remove or kill distant and/or unrecognized metastases.
openaire   +2 more sources

Adjuvant chemotherapy

The Lancet, 2000
Richard Gray   +3 more
openaire   +2 more sources

Adjuvant Chemotherapy

2023
Hoon Jai Chun   +3 more
openaire   +1 more source

Adjuvant Intravesical Chemotherapy

In this section, we reviewed adjuvant intravesical chemotherapy for Non-Muscle invasive bladder cancer. Mitomycin C indicated for the treatment of bladder cancer and effective for low and intermediate-risk tumors.Epirubicin is a doxorubicin analogue. Perioperative epirubicin treatment is appropriate for patients with low-grade ,single sided and up to 3
Ilkin Hamid-Zada, Kenan Toprak
openaire   +1 more source

Adjuvant Chemotherapy

2018
Toshiaki Ishikawa, Hiroyuki Uetake
openaire   +2 more sources

Adjuvant chemotherapy

2012
Uschi Hofmann   +4 more
openaire   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Zsolt Megyesfalvi   +2 more
exaly  

Adjuvant Chemotherapy

2017
Erik L. Zeger, Richard M. Goldberg
openaire   +2 more sources

Home - About - Disclaimer - Privacy